Skip to content

Retrospective study of correlation between contrast encephalopathy and interventional therapy

Retrospective study of correlation between contrast encephalopathy and interventional therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600115953
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-10
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast encephalopathy

Interventions

The incidence group of CIE after neurointervention:None

Sponsors

Zhuhai People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Those who were admitted to the Department of Cerebrovascular Diseases of our hospital from January 01, 2019 to October 20, 2025, and experienced acute neurological impairment after neurological intervention (intra-arterial iodine contrast agent), including focal neurological deficits (hemiplegia, aphasia, hemianopia) and systemic symptoms (vomiting, confusion, seizures, coma, and even cardiac arrest), which can return to normal after about 72 hours of symptomatic treatment.

Exclusion criteria

Exclusion criteria: NA

Design outcomes

Primary

MeasureTime frame
Different types and dosages of contrast agents;

Secondary

MeasureTime frame
Previous history of underlying diseases such as hypertension, diabetes, and coronary heart disease;Blood biochemical test results during hospitalization;General condition, history of smoking and alcohol consumption;

Countries

China

Contacts

Public ContactYu Liu

Zhuhai People's Hospital

liuyuly1982@163.com+86 756 2222569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026